Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Deykin

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Immunology|September 15, 2005
The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN-gamma secretionFiona K Gibbons, Elliot Israel, Aaron Deykin, et al.
Anesthesia and Analgesia|February 25, 2005
Capnogram shape in obstructive lung diseaseBaruch Krauss, Aaron Deykin, Alexander Lam, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2015
Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection FractionStevan P Tofovic, Eman M Salah, Glenn J Smits, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 26, 2006
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantationPhilip A Linden, Richard J Gilbert, Beow Y Yeap, et al.
Journal of Clinical Pharmacology|May 26, 2011
Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairmentZhaoyang Li, Liang-Shang Gan, Thomas Marbury, et al.
Contemporary Clinical Trials|April 2, 2008
Do "placebo responders" exist?Ted J Kaptchuk, John M Kelley, Aaron Deykin, et al.
Clinical Pharmacology and Therapeutics|December 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose TrialDave Singh, Chaim M Brickman, Peter Lloyd, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2022
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosisIh Chang, Ludwig Kappos, Gavin Giovannoni, et al.
Journal of Clinical Pharmacology|October 8, 2010
Effects of BG9928, an adenosine A₁ receptor antagonist, in patients with congestive heart failureStephen S Gottlieb, Barry Ticho, Aaron Deykin, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 22, 2005
Association between oxygen consumption and nitric oxide production during the relaxation responseJeffery A Dusek, Bei-Hung Chang, Jamil Zaki, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Immunology|September 15, 2005
The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN-gamma secretionFiona K Gibbons, Elliot Israel, Aaron Deykin, et al.
Anesthesia and Analgesia|February 25, 2005
Capnogram shape in obstructive lung diseaseBaruch Krauss, Aaron Deykin, Alexander Lam, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2015
Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection FractionStevan P Tofovic, Eman M Salah, Glenn J Smits, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 26, 2006
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantationPhilip A Linden, Richard J Gilbert, Beow Y Yeap, et al.
Journal of Clinical Pharmacology|May 26, 2011
Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairmentZhaoyang Li, Liang-Shang Gan, Thomas Marbury, et al.
Contemporary Clinical Trials|April 2, 2008
Do "placebo responders" exist?Ted J Kaptchuk, John M Kelley, Aaron Deykin, et al.
Clinical Pharmacology and Therapeutics|December 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose TrialDave Singh, Chaim M Brickman, Peter Lloyd, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2022
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosisIh Chang, Ludwig Kappos, Gavin Giovannoni, et al.
Journal of Clinical Pharmacology|October 8, 2010
Effects of BG9928, an adenosine A₁ receptor antagonist, in patients with congestive heart failureStephen S Gottlieb, Barry Ticho, Aaron Deykin, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 22, 2005
Association between oxygen consumption and nitric oxide production during the relaxation responseJeffery A Dusek, Bei-Hung Chang, Jamil Zaki, et al.
Pageof 4